Miraculix Lab is a university-founded startup based in Germany, dedicated to transforming harm-reduction methods through accessible, science-driven solutions. Their flagship offering is the miraculix QTests®, a suite of at-home quantitative testing kits that measure the exact potency of psychoactive substances—including psilocybin, MDMA, LSD, cocaine, THC, and CBD. These kits bridge the gap between traditional reagent tests and full laboratory analysis by offering lab-grade accuracy in a user‑friendly format.
Originally developed at the Friedrich-Schiller University under the direction of Dr. Felix Blei—an internationally recognized expert in natural product biosynthesis—miraculix combines rigorous scientific validation with user-centric product design. The first Psilocybin QTest was created to address the unpredictable strength of magic mushrooms by providing precise potency readings in just 15–30 minutes.
Miraculix Lab’s mission is to empower individuals with the tools they need to make safer, informed decisions about psychoactive substance use. They believe in democratizing access to accurate, lab-grade testing—creating interventions that promote prevention, education, and evidence-based harm reduction without requiring professional laboratory infrastructure.
Led by Dr. Felix Blei (Dr. rer. nat.), Miraculix Lab was inspired by his groundbreaking doctoral research into the biosynthesis of psilocybin in Psilocybe mushrooms. He and his team developed the first precision test kits that made lab-grade potency validation accessible outside professional settings—transforming academic theory into real-world impact.
Email:info@miraculix-lab.com
Phone:1 (509) 870-7678
Website:Miraculix
Address:2525 Millersburg Drive NE, Albany, OR 97321, USA